Serum HE4 and CA125 combined to predict and monitor recurrence of type II endometrial carcinoma

There is no recognized serum biomarker to predict the recurrence of endometrial carcinoma (EC). We aimed to explore serum human epididymis protein 4 (HE4) and cancer antigen 125 (CA125) as the biomarkers to predict and monitor recurrence of type II EC. 191 patients diagnosed with type II EC were inv...

Descripción completa

Detalles Bibliográficos
Autores principales: Quan, Quan, Liao, Qianqian, Yin, Wanchun, Zhou, Shuwei, Gong, Sainan, Mu, Xiaoling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8569215/
https://www.ncbi.nlm.nih.gov/pubmed/34737393
http://dx.doi.org/10.1038/s41598-021-01263-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8569215/
https://www.ncbi.nlm.nih.gov/pubmed/34737393
http://dx.doi.org/10.1038/s41598-021-01263-w

Ejemplares similares